AstraZeneca Receives FDA Approval for Enhertu Breast Cancer Treatment
AstraZeneca received Food and Drug Administration approval for enhertu, its breast cancer treatment developed in partnership with Japanese company Daiichi Sankyo. The Anglo-Swedish pharmaceutical company said Monday that the treatment's approval was based on results from a Phase III trial,
With a focus on healthy living and information on advances in breast cancer treatment, Mayo Clinic is holding an educational ...
Learn vital breast cancer warning signs and early detection methods as statistics show increasing mortality rates among Black ...
Pathologists supported by a new artificial intelligence tool outperformed Standard of Care/Gold standard in determining ...
A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...
Hailee Steinfeld is teaming up with Novartis to raise awareness about breast cancer with an empowering Super Bowl 59 ...
In a candid Instagram post, the star shared the unexpected news of her 8th surgery and the possibility of a 9th.
Triple negative breast cancer wreaks a particularly heavy toll in certain regions and populations, with stark differences in both incidence and survival rates ...
Discover the debate surrounding the labeling of DCIS as a cancer diagnosis and its impact on patient treatment and research ...
Siena basketball's Alden Yergey said she's looking at Thursday's "Pink Zone" game against Marist at UHY Center in a different ...
To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s ...
From China’s milestone in nuclear fusion to researchers testing a breast cancer vaccine on mice, here are seven science ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback